Peptide radiotracer compositions
US9533059B2 · kind B2 · utility
4Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2011 |
| Grant date | Jan 3, 2017 |
| Priority date | — |
| Expiry date | Nov 16, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1833
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to imaging agent compositions comprising radiolabelled c-Met binding peptides suitable for positron emission tomography (PET) imaging in vivo. The c-Met binding peptides are labelled with the radioisotope 18F. Also disclosed are pharmaceutical compositions, methods of preparation of the agents and compositions, plus methods of in vivo imaging using the compositions, especially for use in the management of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.